Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Opens Sample-Analysis Lab in Scotland; Plans to Expand in Asia

NEW YORK (GenomeWeb News) — Response Genetics has opened a lab in Scotland to offer genetic analysis services to pharmaceutical companies, and plans to open additional labs in Asia, the company said today.
 
The lab, which is located in Edinburgh and is the company’s second sample-analysis center, is now open and is “fully equipped” to develop diagnostics and analyze clinical trial samples and is in line with “current quality assurance guidelines,” the company said.
 
Response Genetics also has a genetic-analysis lab in Los Angeles, where it is headquartered.
 
The Scotland facility is “the first step towards implementing the corporate strategy to standardize genetic testing globally,” Response CEO Kathleen Danenberg said in a statement.
 
“We expect to continue this expansion with the opening of new laboratories in Asia,” she added.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.